Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Breast (Edinburgh, Scotland)|May 27, 2014
Optical segmentation of unprocessed breast tissue for margin assessmentRebecca A Wilson, James M Zavislan, Linda M Schiffhauer
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 22, 2009
Metastatic versus primary oncocytic papillary adenocarcinoma of the endometrium: a report of a case and review of the literatureDavid Tretheway, James G Gebhardt, Vikram S Dogra, et al.
Applied Optics|June 14, 2013
Design and validation of two optical beacons for guidewire localization in breast-conserving surgeryRebecca Anne Wilson, Stephen A McAleavey, Linda M Schiffhauer, et al.
BMC Cancer|August 5, 2009
Confocal microscopy of unfixed breast needle core biopsies: a comparison to fixed and stained sectionsLinda M Schiffhauer, J Neil Boger, Thomas A Bonfiglio, et al.
American Journal of Clinical Pathology|March 1, 2023
Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer CohortCansu Karakas, Haley Tyburski, Bradley M Turner, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 18, 2011
Giant pancreatic tumor with clinical characteristics of insulinoma but without common pathologic featuresNancy Ann E Oberheim, Albert Kim, Rachel L Farkas, et al.
American Journal of Clinical Pathology|January 25, 2021
Significance of HER2 in Microinvasive Breast CarcinomaHuina Zhang, Ioana Moisini, Bradley M Turner, et al.
Medical Care|June 19, 2009
The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatmentJennifer J Griggs, Melony E S Sorbero, Gretchen M Ahrendt, et al.
Molecular Cancer Therapeutics|November 24, 2006
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancerElizabeth E Evans, Alicia D Henn, Alan Jonason, et al.
Human Pathology|May 13, 2024
Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomasJanira M Navarro Sanchez, Brian S Finkelman, Haley Tyburski, et al.
Pageof 2